Medicine - Hematology and Medical Oncology

Medicine & Life Sciences

1. Neoplasms 100%
2. Multiple Myeloma 86%
3. Therapeutics 50%
4. Survival 45%
5. Prostatic Neoplasms 40%
6. Primary Myelofibrosis 39%
7. Confidence Intervals 36%
8. Hepatocellular Carcinoma 36%
9. Breast Neoplasms 31%
10. Drug Therapy 31%
11. Leukemia 29%
12. T-Lymphocytes 27%
13. Lung Neoplasms 27%
14. Genes 26%
15. Bone Marrow 26%
16. Mortality 25%
17. Immunotherapy 23%
18. Acute Myeloid Leukemia 23%
19. Head and Neck Neoplasms 23%
20. Carcinoma 23%
21. Meta-Analysis 23%
22. Graft vs Host Disease 22%
23. Polycythemia Vera 21%
24. Odds Ratio 21%
25. Clinical Trials 21%
26. Hematopoietic Stem Cells 21%
27. Hemophilia A 21%
28. Urinary Bladder Neoplasms 20%
29. Biomarkers 20%
30. Transplants 20%
31. Liver 20%
32. Cohort Studies 19%
33. Proteins 19%
34. Mutation 19%
35. Cell Transplantation 18%
36. Case-Control Studies 18%
37. Progression-Free Survival 18%
38. Stem Cells 18%
39. Lenalidomide 17%
40. Myelodysplastic Syndromes 17%
41. Growth 17%
42. Population 17%
43. Acute Promyelocytic Leukemia 17%
44. Dexamethasone 17%
45. Safety 16%
46. Melanoma 16%
47. Cell Line 16%
48. INCB018424 15%
49. Neoplasm Metastasis 15%
50. Incidence 15%
51. Bortezomib 15%
52. Recurrence 15%
53. Castration 15%
54. Apoptosis 15%
55. Cisplatin 14%
56. daratumumab 14%
57. Allogeneic Cells 13%
58. Lymphoma 13%
59. Alcohol Drinking 13%
60. Sickle Cell Anemia 13%
61. Dendritic Cells 13%
62. carfilzomib 12%
63. In Vitro Techniques 12%
64. Epidemiology 12%
65. Systematic Reviews 12%
66. Non-Hodgkin's Lymphoma 11%
67. DNA 11%
68. Pharmaceutical Preparations 11%
69. Smoking 11%
70. Tretinoin 11%
71. Renal Cell Carcinoma 10%
72. Stem Cell Transplantation 10%
73. Azacitidine 10%
74. Phenotype 10%
75. Epigenomics 10%
76. Non-Small Cell Lung Carcinoma 10%
77. Ligands 10%
78. Thrombocytopenia 9%
79. Blood Platelets 9%
80. Arsenic Trioxide 9%
81. selinexor 9%
82. Factor VIII 9%
83. Occupational Exposure 9%
84. Gene Expression 9%
85. Antibodies 9%
86. Antigens 9%
87. Esophageal Squamous Cell Carcinoma 9%
88. B-Lymphocytes 9%
89. Coronavirus 9%
90. Transplantation 9%
91. Pancreatic Neoplasms 9%
92. Oropharyngeal Neoplasms 9%
93. Hematopoietic Stem Cell Transplantation 8%
94. Tumor Microenvironment 8%
95. Infections 8%
96. Squamous Cell Carcinoma of Head and Neck 8%
97. Anemia 8%
98. Smokers 8%
99. Erythropoiesis 8%
100. Serum 8%